NewsRx

Search our medical news database

Vectors

Nautilus Biotech Optimizes AAV Rep Protein To Increase rAAV Productivity

Published in Gene Therapy Weekly, October 25th, 2001

Using its proprietary directed-evolution technology, Nautilus Biotech has developed a collection of rep proteins optimized for the production of rAAV. Biotech companies developing rAAV-based gene therapy products face the productivity bottleneck of how to produce enough amounts of virus to support clinical development and future market needs. Currently, all methodologies for manufacturing rAAV rest on the activity of the AAV rep protein, which is naturally responsible for AAV replication and generation of offspring.

"The optimized rep proteins developed by Nautilus offer a solution to the unmet need of the gene therapy industry, whatever their way to produce the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook